HTHiroyuki Takashima

Hiroyuki Takashima

*This is an algorithmically generated author record based on publicly available information.

Hiroyuki Takashima has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Haruhiko Tamaoki

    Novartis Institutes for BioMedical Research, Novartis, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan, Graduate School of Medical Sciences, University of Kumamoto, 1-1-1, Honjo, Kumamoto 860-8556, Japan, Graduate School of Engineering, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan, and Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan

    1 shared publication
  • Kiichi Fukui

    Novartis Institutes for BioMedical Research, Novartis, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan, Graduate School of Medical Sciences, University of Kumamoto, 1-1-1, Honjo, Kumamoto 860-8556, Japan, Graduate School of Engineering, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan, and Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan

    1 shared publication
  • Naoki Teno

    Novartis Institutes for BioMedical Research, Novartis, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan, Graduate School of Medical Sciences, University of Kumamoto, 1-1-1, Honjo, Kumamoto 860-8556, Japan, Graduate School of Engineering, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan, and Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan

    1 shared publication
  • Susumu Uchiyama

    Department of Biotechnology, Graduate School of Engineering, The University of Osaka, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan

    1 shared publication
  • Yoshinori Nishi

    Novartis Institutes for BioMedical Research, Novartis, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan, Graduate School of Medical Sciences, University of Kumamoto, 1-1-1, Honjo, Kumamoto 860-8556, Japan, Graduate School of Engineering, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan, and Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan

    1 shared publication
  • Yuji Kobayashi

    Novartis Institutes for BioMedical Research, Novartis, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan, Graduate School of Medical Sciences, University of Kumamoto, 1-1-1, Honjo, Kumamoto 860-8556, Japan, Graduate School of Engineering, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan, and Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan

    1 shared publication

Latest Publications

  • Hydrophobic Core around Tyrosine for Human Endothelin-1 Investigated by Photochemically Induced Dynamic Nuclear Polarization Nuclear Magnetic Resonance and Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry

    by Hiroyuki Takashima, Haruhiko Tamaoki, Naoki Teno, Yoshinori Nishi, Susumu Uchiyama, Kiichi Fukui, Yuji Kobayashi

    Human endothelin-1 (ET-1) is a potent cardiovascular bioactive peptide. Its activity is based on the C-terminal residues, e.g., Trp 21 in particular. Recently, we reported an NMR solution structure of ET-1, which has a C-terminal hydrophobic core around Tyr 13. This C-terminal conformation does not agree with a previously reported X-ray crystal structure. To clarify the discrepancy, we performed photo-CIDNP NMR in combination with MALDI-TOF MS. The photo-CIDNP results revealed that the Tyr 13 aromatic ring is concealed in a hydrophobic interaction. MALDI-TOF MS experiments showed this is an intramolecular interaction in monomeric form, which is also supported by sedimentation analysis and two-dimensional NMR cross-peak line shapes. Thus, we confirmed the intramolecular hydrophobic core around Tyr 13 in aqueous solution, which agrees with the solution structure. The C-terminal conformational discrepancy between the solution and crystal was caused by the intermolecular hydrogen bond between Tyr 13 of one molecule and Asp 8 of the other in a dimer-like formation of crystalline ET-1. On the other hand, we indicated that endothelin-3, another isoform of the endothelin, has an apparent self-association equilibrium under the same condition in which three tyrosines participate.